Celanese Corp

CE remains entrenched in a Stage 4 decline, confirmed by the active Support Failure pattern and a clear sequence of lower highs and lower lows. Price continues to trade below the 9-, 21-, 50-, and 200-day moving averages, with rallies into the EMAs repeatedly rejected. Despite extreme oversold readings, there is no visible exhaustion, and downside momentum looks set to continue. Execution should focus on selling into retracements back toward the declining EMAs.

• ↑Projects EPS gain of $1–2 in 2026 on strict cost savings.
• ↑Implements $30M in annual cost reductions to boost margins.
• ↓Revenue fell 10% YoY to $500M amid weak end-market demand.